Breast cancer metastasis to the conjunctiva by Bobić-Radovanović Anica et al.
Vojnosanit Pregl 2013; 70(3): 331–334. VOJNOSANITETSKI PREGLED Strana 331
Correspondence to: Anica  Bobiý Radovanoviý, Clinic of Eye Disease, Clinical Center of Serbia, Pasterova 2, 11 000, Belgrade, Serbia.
Phone.: +381 11 283 50 34, E-mail: chjserbia@hotmail.com
 CASE REPORT                    UDC: 617.711-02::618.19-006-033.2
DOI: DOI: 10.2298/VSP120322040B
Breast cancer metastasis to the conjunctiva
Metastaze karcinoma dojke u konjunktivu
Anica Bobiü Radovanoviü*
†, Dejan Rašiü*
†, Marko Buta
‡, Radan Džodiü*
‡
*Faculty of Medicine, University of Belgrade, Belgrade, Serbia; 
†Clinic of Eye Disease,
Clinical Center of Serbia, Belgrade, Serbia; 
‡Institute of Oncology and Radiology of
Serbia, Belgrade, Serbia
Abstract
Introduction. Conjunctival metastasis is exceedingly rare,
and it is, as a rule, a sign of advanced malignant disease with
poor prognosis. We presented a female patient with breast
cancer metastasis to the conjunctiva. Case report. A 45-year-
old premenopausal female patient was presented with a soli-
tary, yellowish, thin, demarcated lesion in the superior nasal
quadrant of the bulbar conjunctiva of the left eye noted by
chance a week earlier. There was no sign of irritation, and no
pain, and no other functional or morphological problem in
either eye or orbit. Five years before the appearance of con-
junctival metastasis, breast carcinoma was diagnosed and the
patient underwent chemotherapy, preoperative radiotherapy
and radical mastectomy. Three years later, computed tomog-
raphy scan showed metastasis in the left hepatic lobe with as-
cites and the patient underwent chemotherapy again. But,
four months prior to the appearance of conjunctival lesion
body scintigraphy showed multifocal sceletal lesions and nu-
clear magnetic resonance revealed diffuse hepatic metastases
and bilateral ovarial tumors. Paliative radiotherapy and hor-
monal therapy (megestrol, 160 mg) were carried out. An exci-
sional biopsy of the observed conjunctival lesion was per-
formed under topical anesthesia and the material was sub-
jected to histopathological (HP) examination. HP and immu-
nohistochemical examinations established the presence of
breast infiltrating lobular carcinoma metastatic to the con-
junctiva. The patient showed rapid deterioration after inter-
vention, and died after three weeks. Conclusion. A survival
period less than one month after the appearance of conjunc-
tival metastasis deserves attention because it is unexpected
and has never been reported previously. It is not a rule that
HP presentation of a metastatic lesion is so characteristic that
it is possible to determine a primary tumor.
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Apstrakt
Uvod. Metastaze u konjunktivu izuzetno su retke i, po
pravilu, znak su uznapredovale maligne bolesti sa lošom
prognozom. Prikazali smo bolesnicu sa metastazom karci-
noma dojke u konjunktivu. Prikaz bolesnika. Bolesnica,
stara 45 godina, pri dolasku imala je solitarnu, žuýkastu,
tanku i ograniÿenu leziju u gornjem nazalnom kvadrantu
bulbarne konjunktive levog oka, koja je sluÿajno zapažena
nedelju dana ranije. Nije bilo znakova iritacije niti bola,
kao ni drugih funkcionalnih ni morfoloških problema u
oku ili orbiti. Pet godina ranije dijagnostikovan je karci-
nom dojke. Bolesnica je leÿena hemioterapijom, preopera-
tivnom radioterapijom i uraĀena je radikalna mastektomija.
Tri godine ranije, kompjuterizovanom tomografijom utvr-
Āene su metastaze u levi hepatiÿki lobus sa ascitesom i
bolesnica je ponovo leÿena hemioterapijom. MeĀutim, ÿe-
tiri meseca pre pojave konjunktivalne lezije, scintigrafijom
su utvrĀene multifokalne lezije u kostima dok su nuklear-
nom magnetnom rezonancom otkrivene difuzne metastaze
u jetru i obostrano ovarijalni tumor. Sprovedena je palija-
tivna radioterapija i hormonska terapija (megestrol, 160
mg). UraĀena je ekscizijska biopsija uoÿene konjunktivalne
lezije u lokalnoj anesteziji i materijal poslat na histopatolo-
ški pregled. Histopatološkim i imunohistohemijskim ispiti-
vanjem utvrĀena je metastaza infiltrišuýeg lobularnog kar-
cinoma dojke u konjunktivu. Stanje bolesnice nakon inter-
vencije rapidno se pogoršavalo i umrla je nakon tri nedelje.
Zakljuÿak. S obzirom na to da je neoÿekivano i da do sa-
da nije bilo registrovano, preživljavanje kraýe od jednog
meseca od pojave metastaze u konjunktivu zaslužuje po-
sebnu pažnju. Nije uobiÿajeno da je histopatološka slika
metastatske lezije toliko karakteristiÿna da je na osnovu nje
moguýe definisati primarni tumor.
Kljuÿne reÿi:
konjunktiva; neoplazme, metastaze; dijagnoza;
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Introduction
The exact incidence of metastatic tumors to the eye and
adnexa is unknown, and the supposed incidence is probably
underestimated. A certain number of these metastases are
asymptomatic and remain unrecognized. Some of them are
not appreciated because of the dominant problems with si-
multaneous tumor involvement of major organs. The sys-
temic treatment of primary or metastatic disease may also
cause regression of ocular metastases as a side effect. On the
other hand, the number of tumor patients increases, their sur-
vival is prolonged, thus making the possibility of ocular me-
tastases greater.
Among the metastases to the eye and adnexa the most
common are intraocular, choroidal metastases, and orbital
metastases.
Conjunctival metastases of distant solid tumors are ex-
tremely rare. In an experiment on rabbits, only one case of
conjunctival metastasis was identified among 67 ocular me-
tastases after injection of Brown-Pearce tumor cells into the
left ventricle 
1. A clinical survey of 1,643 patients treated for
conjunctival tumors over a 28-year-period revealed only 13
cases of metastatic tumor, less than 1% 
2.
Breast carcinoma, being the most frequent malignancy
in female population, is also the most frequent site of pri-
mary tumor to give ophthalmic metastases in females 
3, 4.
Autopsy studies have found the presence of ocular me-
tastases in 8.3% 
5, 36% 
6 and even 41% 
7 of patients who
died of breast carcinoma. In a clinical series the incidence of
ocular metastases in patients with breast carcinoma is be-
tween 8% and 10% 
8, 9. However, screening for ophthalmic
involvement in 68 visually asymptomatic patients with lo-
cally advanced or metastatic breast carcinoma after a median
period of 5 years from the diagnosis of cancer, has shown
only one case of orbital metastasis, a deposit in the lateral
rectus muscle, three cases of ophthalmic manifestations of
neurological problems, and two cases of ocular complica-
tions of treatment. The conclusion of the study was that there
was, therefore, no need for routine screening 
10.
Breast carcinoma is the most common malignancy to
metastasize to the conjunctiva. Shields et al. 
2 found that
breast cancer is a primary tumor site for 39% of conjunctival
metastases.
In Serbia there is only one Laboratory for Ophthal-
mopathology, and despite its 60-year history this was the
firts diagnosed conjunctival metastasis of breast carcinoma.
Case report
A 45-year-old premenopausal female patient was pre-
sented with solitary, yellowish, thin, demarcated lesion in the
superior nasal quadrant of the bulbar conjunctiva of the left
eye. There was no sign of irritation, and no pain. The lesion
had been noted by chance a week earlier. An ophthalmologic
examination showed no other functional or morphological
problems in either eye or orbit.
Five years before the patient had presented with 30 mm
lump in the left breast, passive infiltration of the overlaying
skin and left axillary lymphadenopathy. Tumor biopsy
showed lobular infiltrative breast carcinoma with estrogen
receptor (ER) and progesterone receptor (PGR) positive and
human epidermal growth factor receptor (HER) 2+ negative
receptors. Patient underwent IV cycles of FAC chemother-
apy, preoperative radiotherapy of the left breast and radio-
castration, followed by left modified radical mastectomy
(Madden). Sixteen of the 17 removed axillary lymph nodes
were positive. The patient received V more cycles of FAC
chemotherapy to the cumulative dose and 20 mg tamoxifen
daily was introduced. Three years later computed tomogra-
phy (CT) scan showed metastasis in the left hepatic lobe, 20
mm in diameter with ascites. The patient underwent VIII cy-
cles of taxol CBDCA chemotherapy followed by anastrozole
1 mg daily. Four months prior to conjunctival lesion body
scintigraphy showed multifocal skeletal lesions, and nuclear
magnetic resonance (NMR) revealed diffuse hepatic metasta-
ses and bilateral ovarial tumors. Palliative radiotherapy and
megestrol 160 mg were carried out.
An excisional biopsy of the conjunctival lesion was per-
formed under topical anesthesia and a material was subjected
to histopathological examination.
Within conjunctival connective tissue stroma histopa-
thology revealed the presence of small, round and ovoid tu-
mor cells with little cytoplasm and with visible intracyto-
plasmic lumina. The nuclei of those tumor cells were more
or less eccentrically placed with little pleomorphism. Mitoses
were infrequent. Tumor cells exhibited a diffuse infiltrative
pattern with a single file of “targetoid” infiltration. Conjunc-
tival epithelium was unremarkable (Figure 1).
Fig. 1 – A) A conjunctival subepithelial tumor nodule. Intact
overlying epithelium exibits no pathology, entire
conjunctival substantia propria  is diffusely involved by
tumor calls, resection lines are free >Haematoxylin and Eosin
(H&E), original magnification u 40]; B) Small, round and
ovoid tumor cells with little cytoplasm and with visible
intracytoplasmatic lumina, arranged in single files and/or
cords, exhibit infiltrative pattern. A marked vascularisation
of tumor nodule is also evident (H&E, original magnification
u 200); C) Nuclei of the tumor cells more or less eccentrically
placed with little pleomorphism are well preserved, some of
them with a vesicular appearance and also with prominent
nucleoli. Mitoses are infrequent. Also, there is a single file of
“targetoid” pattern/infiltration (H&E, original
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Immunohistochemical phenotype was: ER + ; HER-
2/neu (c-erB/2) -; E/cadherin - ; CK17 -; BRCA1 + ; EMA +
(Figure 2).
Histopathological and immunohistochemical examina-
tion established the presence of breast infiltrating lobular
carcinoma metastatic to the conjunctiva.
The presented patient showed rapid deterioration after
the intervention, and died three weeks later.
Discussion
Conjunctival metastases are most commonly localized on
the bulbar conjunctiva. All 13 conjunctival metastatic tumors
reported by Shields et al. 
2 had bulbar localization. Three out
of four metastases of breast carcinoma were on the bulbar
conjunctiva 
11. Clinical presentation of conjunctival metastasis
is not characteristic. It usually presents a solitary, yellowish,
painless lesion not adherent to the underlying sclera with a
variable amount of conjunctival irritation. The presented pa-
tient referred with an unremarkable lesion of the bulbar con-
junctiva, which is typical for conjunctival metastasis.
There is currently no consensus on the treatment of
conjunctival metastasis and the therapeutic modality must be
individualized. Treatment modalities are excision, local ra-
diotherapy and systemic chemotherapy. In the presented case
an excisional biopsy was both a diagnostic and therapeutic
procedure.
Conjunctival metastasis of breast carcinoma usually oc-
curs after a relatively long period of time, a few years after
diagnosis of the primary tumor. The interval between diag-
nosis of primary and secondary tumor was more than 5 years
in Kiratli et al. study 
11, but Skalicky et al. 
12 reported a case
of conjunctival metastasis after only 9 months. In the pre-
sented patient conjunctival metastasis was recognized 5
years after the diagnosis of breast tumor.
As a rule, conjunctival metastases are a part of an ad-
vanced malignant disease, with other organs or ocular struc-
tures already involved. In the study of Kiratli et al. 
11 only 2
out of 10 patients with conjunctival metastasis, and only 1of
4 patients with conjunctival metastasis of breast carcinoma
were free of nonocular metastases at the appearance of con-
junctival metastasis. Two out of 4 patients with conjunctival
metastasis of breast carcinoma had a concurrent choroidal
metastasis. Benzimra et al. 
13 reported a case of metastatic
breast carcinoma to the anterior chambre angle and conjunc-
tiva. The presented patient experienced no other ocular me-
tastases, but multiple bone and liver metastases were present.
The prognosis of patients with conjunctival metastases
is mainly poor. The main survival time reported for patients
with conjunctival metastasis is 9 months, but for patients
with conjunctival metastasis of breast carcinoma it is a little
bit longer, 14 months 
11. Our patient died only three weeks
after the diagnosis of conjunctival metastasis. Such a short
survival period is very unusual and totally unexpected. This
could reflect more aggressive tumor biology in stage IV
breast cancer patient.
A histopathological picture of a metastatic tumor may
recapitulate the appearance of the primary lesion, or it may
appear less differentiated. It is not always possible to differ-
entiate a primary tumor on the basis of metastasis. In the pre-
sented case the histopathologic appearance of conjunctival
metastasis was typical enough to make the right diagnosis.
Conclusion
We reported exceedingly rare conjunctival metastasis of
breast carcinoma. The interval between diagnosis of the pri-
mary tumor and conjunctival metastasis, the presence of syn-
chronous or metachronous metastases, the location and clinical
presentation of conjunctival lesion and local treatment methods
have been discussed. Histopathologic presentation of a meta-
static lesion is not by the rule so characteristic to make it possi-
ble to determine the primary tumor. A survival period less than
one month after the appearance of conjunctival metastasis was
unexpected and had never been reported previously.
Conjunctival metastases of breast carcinoma, although
uncommon, have clinical importance as the signs of the ad-
vanced stage of a systemic malignant disease with poor
prognosis. The clinical presentation of metastasis is unre-
markable, neverthless it certenly should attract full atten-
tion of an ophthalmologist, and deserves appropriate treat-
ment.
Fig. 2 – Immunohistochemical staining of tumor cells suggesting an infiltrative
lobular breast carcinoma metastatised to the conjunctiva (u 100)Strana 334 VOJNOSANITETSKI PREGLED Volumen 70, Broj 3
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